Skip to content

Dimension Therapeutics, Inc.

CIK 0001592288

← back to feed
Revenue (TTM)
$15.23M
+49.6% YoY Q3 Oct 2017
Net Income (TTM)
−$57.11M
−39.8% YoY Q3 Oct 2017
EPS Diluted (TTM)
—
Q3 Oct 2017
Gross Margin
—
Q3 Oct 2017
Operating Margin
-375.4%
Q3 Oct 2017
Net Margin
-375.0%
Q3 Oct 2017
Free Cash Flow (TTM)
—
Q3 Oct 2017
Cash
$14.55M
Q3 Oct 2017
Total Debt
—
Q3 Oct 2017
Shares Outstanding
25.37M sh
Q3 Oct 2017

Revenue & Net Income

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings